Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.

Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.

Item
http://www.wikidata.org/entity/Q30827853
Intravenous thrombolysis for acute ischaemic stroke in the elderly: data from the Baden-Wuerttemberg stroke registry.Nicotinamide Administration Improves Remyelination after Stroke."Weekend effect" on stroke mortality revisited: Application of a claims-based stroke severity index in a population-based cohort study.Hypothermia Protects and Prolongs the Tolerance Time of Retinal Ganglion Cells against Ischemia.Access, timing and frequency of very early stroke rehabilitation - insights from the Baden-Wuerttemberg stroke registry.Thrombolysis in Stroke within 30 Minutes: Results of the Acute Brain Care Intervention Study.Centralising and optimising decentralised stroke care systems: a simulation study on short-term costs and effectsPublic Awareness of Stroke and Its Predicting Factors in Korea: a National Public Telephone Survey, 2012 and 2014.Prehospital and intra-hospital time delays in posterior circulation stroke: results from the Austrian Stroke Unit Registry.Diurnal Variation of Intravenous Thrombolysis Rates for Acute Ischemic Stroke and Associated Quality Performance Parameters.A System-Based Intervention to Improve Access to Hyperacute Stroke Care.Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset.The Association of Decision-to-Incision Time for Cesarean Delivery with Maternal and Neonatal Outcomes.[Could it be a stroke?].Development and validation of a penumbra-based predictive model for thrombolysis outcome in acute ischemic stroke patients
P2860

Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.

Item
http://www.wikidata.org/entity/Q30827853
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Time to treatment with recombi ...... om randomised clinical trials.
@ast
Time to treatment with recombi ...... om randomised clinical trials.
@en
type
label
Time to treatment with recombi ...... om randomised clinical trials.
@ast
Time to treatment with recombi ...... om randomised clinical trials.
@en
prefLabel
Time to treatment with recombi ...... om randomised clinical trials.
@ast
Time to treatment with recombi ...... om randomised clinical trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Time to treatment with recombi ...... rom randomised clinical trials
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P932